How much did Artax Biopharma raise?

Artax Biopharma raised $2 Million in a Seed round on May 4, 2020.

Where is Artax Biopharma based and how big is it?

Artax Biopharma is based in Cambridge, Massachusetts, United States. Fundz records about 13 employees.

Who are the decision-makers at Artax Biopharma?

Fundz holds 1 contact at Artax Biopharma, including the Director. Names and contact details are shown to Fundz members.

Artax Biopharma, Inc. reported raising $2 Million in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEMay 04, 2020

Amount Raised

$2 Million

$2 Million sold, per SEC Form D (first sale May 4, 2020)

Round Type

Seed

CambridgeBiotechnology

Quick answer

Artax Biopharma raised $2 Million in a Seed round, dated May 4, 2020. Artax Biopharma is based in Cambridge, Massachusetts, United States.

How much did Artax Biopharma raise?: Artax Biopharma raised $2 Million in a Seed round on May 4, 2020.
What does Artax Biopharma do?: Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases.
Where is Artax Biopharma based and how big is it?: Artax Biopharma is based in Cambridge, Massachusetts, United States. Fundz records about 13 employees.
Who are the decision-makers at Artax Biopharma?: Fundz holds 1 contact at Artax Biopharma, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Artax Biopharma that raised within 45 days of this round, from Fundz verified event records.

Imbed Biosciences Inc. raised $1.5M (Seed) on June 18, 2020.
RHEONIX INC raised an undisclosed amount on June 18, 2020.
Engrail Therapeutics raised $32M (Series A) on June 18, 2020.
Trailhead Biosystems raised $8.6M on June 18, 2020.
Bolt Navigation raised $590K (Seed) on June 18, 2020.
Checkmate Pharmaceuticals, Inc. raised $85M on June 18, 2020.

Who to call at Artax Biopharma, and when

A new round usually means Artax Biopharma is about to hire and buy. The teams that reach out first get the meeting.

An alert the day Artax Biopharma raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Artax Biopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Artax Biopharma. With Fundz connected, it knows.

Watch Fundz in

See plan options

Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Artax Biopharma

Location

1 BROADWAY

Cambridge, Massachusetts, United States

About

Artax Biopharma is a development-stage biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases. Artax Biopharma is developing the next generation of drugs targeting the interaction between TCR and Nck, which is responsible for T-cell activation. Specific control over T-cells through TCR, provides the compounds with the potential to become first-in-class immunomodulators for the treatment of a wide range of autoimmune and inflammatory diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Artax Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Book a demo Explore plans

Related People

1 contact

Verified contactsAndre H., Director hidden hiddenSee plans and pricing

Predictive Intelligence

Strategic

ML-powered predictions for Artax Biopharma's next move

See what Strategic adds

Artax Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

Show me how a sales rep uses this Or see plans and pricing →

5 screens from a live account. No signup.